A research study comparing the effect of different dosing conditions on blood levels of semaglutide in a new tablet composition in healthy participants

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503949-65-00

Acronym

NN9924-4977

Enrollment

120

Registered

2023-07-21

Start date

2023-08-07

Completion date

2024-04-18

Last updated

2023-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026